Gastrointestinal tract involvement in undifferentiated pleomorphic sarcoma (UPS) is extremely rare. To the authors' knowledge, only 21 cases of primary small bowel UPS have been reported in the literature available in English. Reported CT findings in primary small bowel UPS have been nonspecific, and MRI findings have been reported in only one case. The present article describes a case involving a 72-year-old male with histologically confirmed primary UPS arising from the ileum, focusing on both CT and magnetic resonance enterography findings. On CT, primary small bowel UPS was noted as a heterogeneously enhanced small bowel mass without obstruction. Magnetic resonance enterography revealed heterogeneous intermediate T1 and T2 signal intensity, with hemorrhagic or necrotic foci within the mass and heterogeneous enhancement. The differential diagnosis included malignant gastrointestinal tumor; however, the prognosis of UPS is worse, with higher incidences of extra-abdominal metastasis.
INTRODUCTION
In the past, undifferentiated pleomorphic sarcoma (UPS) was often referred to as malignant fibrous histiocytoma, which is the pleomorphic variant of undifferentiated soft tissue sarcoma, a heterogeneous group exhibiting no identifiable line of differentiation of soft tissue sarcoma. UPS occurs primarily in older adults and may be found in any location, but most commonly in the lower extremities, followed by the retroperitoneum. Gastrointestinal (GI) tract involvement in UPS is extremely rare, with only 21 cases of primary UPS of the small bowel reported in the literature available in English. Among these 21 cases, 13 reports described CT findings, and only one described MRI findings in small bowel UPS.
We report a case of UPS arising in the proximal ileum, and emphasize on the use of small bowel cross-sectional imaging, and this is the first case of small bowel UPS describing both CT and MR enterography findings.
CASE REPORT
A 72-year-old man visited the authors' institution complaining of chest pain for 3 days. No other symptoms, such as abdominal pain or weight loss, were noted. He had past history of coronary arterial disease and diabetes mellitus. Transfemoral coronary angiography was performed and unstable angina was suspected for the cause of the chest pain. On the physical examination, the abdomen was soft and non-tender, and no mass was palpable. Laboratory investigations revealed severe anemia and elevated white blood cell count and C-reactive protein level (hemoglobin, 5.8 g/dL; C-reactive protein, 60.2 mg/L; white blood cell count, 16570/µL). Stool hemoglobin level was high (225 ng/mL) and suggestive of GI bleeding. Although emergency esophagogastroduodenoscopy and sigmoidoscopy were performed, there was no significant bleeding focus. Therefore, CT enterography was performed to exclude small bowel bleeding.
CT enterography (using oral contrast for adequate luminal distention) revealed a lobulated contoured polypoid intraluminal mass in the ileum measuring 6.8 × 6.2 × 3.8 cm (Fig. 1A) .
After intravenous contrast administration, the mass exhibited heterogeneous enhancement on the arterial and portal phases. There was no evidence of obstruction, and mucosal and submucosal layer involvement was suspected. There was no significant lymphadenopathy or metastatic lesions in the abdominopelvic cavity or retroperitoneum. Initial assessment based on CT enterography findings was GI stromal tumor (GIST). The differential diagnosis included lymphoma or primary ileal adenocarcinoma.
MR enterography was performed six days later, which revealed that the location of the mass changed, and the mass was now located in the lower mid abdomen (Fig. 1B-E) . There was no local invasion or desmoplastic reaction by the mass. The mass exhibited heterogeneous, intermediate T1 ( 1E ). On T2-weighted imaging, there were tiny, multifocal high SI foci in the mass, suggesting necrosis (Fig. 1C ). In the dynamic study, the mass exhibited tiny, multifocal low SI areas with-Small Bowel Undifferentiated Pleomorphic Sarcoma out enhancement, also suggestive of necrosis or hemorrhagic spots (Fig. 1D) . The final assessment was malignant tumor of the ileum, such as malignant GIST.
The patient underwent laparoscopic segmental resection of the ileum. The mass was located 30 cm above the terminal ileum and there was no adhesion. On gross examination, a 12.4 A. CT enterography revealing a mass 6.8 cm in size at the ileum, exhibiting endoluminal and exoluminal growth. On the portal phase, the mass exhibits heterogeneous enhancement (arrow). B. On T1WI in MR enterography, the mass exhibited heterogeneous intermediate signal intensity (arrow). C. On T2WI, the mass exhibited heterogeneous intermediate signal intensity with T2 hyperintense foci (arrow). D. On T1WI (fat suppressed), 70 s after intravenous contrast administration, the mass exhibited heterogeneous enhancement with non-enhancing foci (arrow). E. On the ADC map, the mass exhibited diffuse restriction with a low ADC value (arrow). × 7.9 × 3.8 cm exophytic soft mass was identified in the ileal wall (Fig. 1F) . The mass passed though all layers, and the center of the mass was located in the subserosal layer. A dissected surface of the mass exhibited variegated appearance composed of whitish-gray, soft, fishflesh appearance with multifocal geographic hemorrhagic and necrotic foci. Microscopic examination revealed a relatively demarcated multilobulated tumor involving the mucosal to serosal layers. Necrotic and hemorrhagic change was observed, especially in the outer portion. The mass exhibited solid sheets of malignant tumor cells, which were a mixture of spindle cells arranged in a vague fascicular pattern, loosely cohesive epithelioid cells with abundant dense eosinophilic cytoplasm and eccentric nuclei, and pleomorphic cells. In addition, a considerable number of bizarre, multinucleated tumor giant cells were scattered (Fig. 1F) . On immunohistochemistry, the tumor cells were negative for cytokeratin, smooth muscle actin, desmin, MyoD1, myogenin, c-kit, CD34, HMB45, Melan-A, and S-100 protein.
The final diagnosis was UPS, Federation Nationale des Centres de Lutte le Cancer grade 3.
One week after surgery, the patient developed motor weakness and sensory impairment of the left upper extremity. Brain MRI revealed multiple enhancing nodules with hemorrhage and edema, suggesting brain metastasis. The patient died 3 months later due to clinical deterioration.
DISCUSSION
UPS is a heterogeneous group of soft tissue sarcomas that are known to occur in all parts of the body, but most commonly in the extremities. Despite its ubiquity, small bowel UPS is an extremely rare disease; consequently, few cases have been reported, with only 21 reported in the literature available in English to date. In our literature review, clinical symptoms and signs of small bowel UPS were nonspecific and included abdominal pain, vomiting, fever, weight loss, GI bleeding, and intussusception. In our patient, anemia found incidentally was the initial presentation, and the GI bleeding was suspected due to high stool hemoglobin levels.
Among the 21 previously reported cases, CT findings in primary small bowel UPS were described in 13 and were nonspecific ( Table 1) . The findings were usually described simply as 'small bowel tumor' or 'small bowel intussusception with suspicious tumor.' Karki et al. (1) analyzed 12 cases of primary ileal UPS. The authors described the characteristic findings of small bowel UPS, demonstrating that it was relatively smaller in size than UPS in other parts of the body. They also described its exophytic nature with intraluminal and intramural growth, which were characteristics similar to those noted our case. In addition, 4 cases of small bowel UPS were reported in Korean, and in two cases, aneurysmal dilatation of small bowel involved by UPS was noted (2) . MRI was performed in 2 cases reported in the literature available in English (3, 4) . Imaging findings were, however, described in only 1 case (4) as a pelvic mass, with T1 intermediate and T2 high SI without mention of an enhancement study. high SI may represent necrotic portions, and non-enhancing portions on dynamic study suggest necrosis or hemorrhagic portions.
Our primary diagnosis was malignant GIST based on CT and MR enterography findings.
Small bowel GIST often presents as an exophytic mass and may be accompanied by endoluminal or both exo-and endoluminal growth. GIST may exhibit internal hemorrhage or necrosis (6) . The present case involved a large mass with both exo-and endoluminal growth with heterogeneous enhancement, and was difficult to diagnose as anything other than malignant GIST based on imaging findings and incidence. Other possible diagnoses include lymphoma or primary ileal adenocarcinoma.
The most common metastasis sites of malignant GIST are the liver and peritoneum. Extraabdominal metastasis of GIST is very uncommon (7) . In the present case, brain metastasis developed rapidly, which may be an additional clue to differentiate small bowel malignant tumors from GIST. Kobayashi et al. (4) analyzed 25 cases (20 of which were reported in Japanese) of primary small bowel UPS, and its prognosis was very poor, with 1-and 2-year survival rates of 53.6% and 42.9%, respectively. The prognosis of malignant GIST is better: 1-year relative (compared with the general United States population) survival rate 80%; 5-year survival rate 45% (8) .
We reported a case of small bowel UPS presenting as a large, polypoid, heterogeneously enhancing mass without obstruction or intussusception. The mass exhibited endo-and exoluminal growth patterns, internal necrosis and hemorrhage, and diffusion restriction. Because of its nonspecific imaging findings, small bowel UPS is usually diagnosed as GIST after imaging studies. Radiologists should be aware that UPS can occur in the GI tract, including 
